A Comparative Study of Two In Vivo PET Verification Methods in Clinical Cases
CORRECTION article
Corrigendum: A Comparative Study of Two In Vivo PET Verification Methods in Clinical Cases
Provisionally accepted- 1 Sichuan University, Chengdu, China
- 2 Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China
- 3 Shanghai Key Laboratory of Radiation Oncology, Shanghai, China
- 4 Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai Cancer Center, Fudan University, Shanghai, Shanghai Municipality, China
• please read through all the templates before choosing • pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Template continues on the next page
Keywords: Proton therapy, breast cancer, positron emission tomography, Depth verification, Methods comparison
Received: 08 Oct 2024; Accepted: 31 Oct 2024.
Copyright: © 2024 Zhang and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jingyi Cheng, Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.